Nalaganje...
Development of a high-throughput homogeneous AlphaLISA drug screening assay for the detection of SARS-CoV-2 Nucleocapsid
The coronavirus disease 2019 (COVID-19) pandemic caused by Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) is in urgent need of therapeutic options. High-throughput screening (HTS) offers the research field an opportunity to rapidly identify such compounds. In this work, we have develop...
Shranjeno v:
| izdano v: | bioRxiv |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Cold Spring Harbor Laboratory
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7444285/ https://ncbi.nlm.nih.gov/pubmed/32839774 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.08.20.258129 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|